2-hydroxy-ethanesulfonate salt

Details for Australian Patent Application No. 2009282521 (hide)

Owner AstraZeneca AB Pulmagen Therapeutics (Synergy) Limited

Inventors Nadin, Alan John

Agent Freehills

Pub. Number AU-A-2009282521

PCT Pub. Number WO2010/019099

Priority 0814729.0 12.08.08 GB; 0814728.2 12.08.08 GB

Filing date 11 August 2009

Wipo publication date 18 February 2010

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61K 31/42 (2006.01) - Oxazoles

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/019099 Priority application(s): WO2010/019099

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282522-A new crystalline form of 4- (5- { (IR) -1- [5- (3chlorophenyl) isoxazol-3-yl] ethoxy } -4-methyl-4H-l, 2, 4triazol-3-yl) pyridine

2009282520-Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist